BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 21844436)

  • 1. Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database.
    Gedaly R; Daily MF; Davenport D; McHugh PP; Koch A; Angulo P; Hundley JC
    Arch Surg; 2011 Aug; 146(8):953-8. PubMed ID: 21844436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation and neuroendocrine tumors: lessons from a single centre experience and from the literature review.
    Bonaccorsi-Riani E; Apestegui C; Jouret-Mourin A; Sempoux C; Goffette P; Ciccarelli O; Borbath I; Hubert C; Gigot JF; Hassoun Z; Lerut J
    Transpl Int; 2010 Jul; 23(7):668-78. PubMed ID: 20478000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study.
    Le Treut YP; Grégoire E; Klempnauer J; Belghiti J; Jouve E; Lerut J; Castaing D; Soubrane O; Boillot O; Mantion G; Homayounfar K; Bustamante M; Azoulay D; Wolf P; Krawczyk M; Pascher A; Suc B; Chiche L; de Urbina JO; Mejzlik V; Pascual M; Lodge JP; Gruttadauria S; Paye F; Pruvot FR; Thorban S; Foss A; Adam R;
    Ann Surg; 2013 May; 257(5):807-15. PubMed ID: 23532105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival.
    Sarmiento JM; Heywood G; Rubin J; Ilstrup DM; Nagorney DM; Que FG
    J Am Coll Surg; 2003 Jul; 197(1):29-37. PubMed ID: 12831921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Younger Age Is Associated with Improved Survival in Patients Undergoing Liver Transplantation Alone for Metastatic Neuroendocrine Tumors.
    Valvi D; Mei X; Gupta M; Shah MB; Ancheta A; Marti F; Gedaly R
    J Gastrointest Surg; 2021 Jun; 25(6):1487-1493. PubMed ID: 32632728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
    Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
    Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.
    Chambers AJ; Pasieka JL; Dixon E; Rorstad O
    Surgery; 2008 Oct; 144(4):645-51; discussion 651-3. PubMed ID: 18847650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resection prior to liver transplantation for hepatocellular carcinoma.
    Belghiti J; Cortes A; Abdalla EK; Régimbeau JM; Prakash K; Durand F; Sommacale D; Dondero F; Lesurtel M; Sauvanet A; Farges O; Kianmanesh R
    Ann Surg; 2003 Dec; 238(6):885-92; discussion 892-3. PubMed ID: 14631225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-year experience with liver transplantation for hepatocellular carcinoma.
    Island ER; Pomposelli J; Pomfret EA; Gordon FD; Lewis WD; Jenkins RL
    Arch Surg; 2005 Apr; 140(4):353-8. PubMed ID: 15837885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database.
    Austin MT; Leys CM; Feurer ID; Lovvorn HN; O'Neill JA; Pinson CW; Pietsch JB
    J Pediatr Surg; 2006 Jan; 41(1):182-6. PubMed ID: 16410130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival.
    van Vilsteren FG; Baskin-Bey ES; Nagorney DM; Sanderson SO; Kremers WK; Rosen CB; Gores GJ; Hobday TJ
    Liver Transpl; 2006 Mar; 12(3):448-56. PubMed ID: 16498656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for unresectable neuroendocrine tumor liver metastases.
    Rossi RE; Burroughs AK; Caplin ME
    Ann Surg Oncol; 2014 Jul; 21(7):2398-405. PubMed ID: 24562931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation.
    Cherqui D; Laurent A; Mocellin N; Tayar C; Luciani A; Van Nhieu JT; Decaens T; Hurtova M; Memeo R; Mallat A; Duvoux C
    Ann Surg; 2009 Nov; 250(5):738-46. PubMed ID: 19801927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.
    Margarit C; Escartín A; Castells L; Vargas V; Allende E; Bilbao I
    Liver Transpl; 2005 Oct; 11(10):1242-51. PubMed ID: 16184539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-1-antitrypsin deficiency: outcomes after liver transplantation.
    Kemmer N; Kaiser T; Zacharias V; Neff GW
    Transplant Proc; 2008 Jun; 40(5):1492-4. PubMed ID: 18589136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registry.
    Lerut JP; Orlando G; Adam R; Schiavo M; Klempnauer J; Mirza D; Boleslawski E; Burroughs A; Sellés CF; Jaeck D; Pfitzmann R; Salizzoni M; Söderdahl G; Steininger R; Wettergren A; Mazzaferro V; Le Treut YP; Karam V;
    Ann Surg; 2007 Dec; 246(6):949-57; discussion 957. PubMed ID: 18043096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases.
    Berber E; Flesher N; Siperstein AE
    World J Surg; 2002 Aug; 26(8):985-90. PubMed ID: 12016479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of treatment of hepatocellular carcinoma before liver transplantation on post transplant tumor recurrence and survival].
    Díaz-Sánchez A; Matilla A; Núñez O; Merino B; Peligros I; Rincón D; Salcedo M; Lo Iacono O; Vega Catalina M; Clemente G; Bañares R
    Gastroenterol Hepatol; 2010 Mar; 33(3):155-64. PubMed ID: 19945770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of unknown primary tumors in patients with neuroendocrine liver metastases.
    Wang SC; Parekh JR; Zuraek MB; Venook AP; Bergsland EK; Warren RS; Nakakura EK
    Arch Surg; 2010 Mar; 145(3):276-80. PubMed ID: 20231629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.